Patent 7276502 was granted and assigned to Vertex Pharmaceuticals on October, 2007 by the United States Patent and Trademark Office.
The present invention relates to compounds useful of inhibitors of protein kinases. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.